A meta-analysis also revealed that OCT4 expression was correlated with tumor sizes, tumor numbers, cell differentiation, and the TNM stage, and that OCT4 expression was associated with poor 3- and 5-year OS and DFS rates in HCC.20 This evidence concerns the gene POU5F1 and hepatocellular carcinoma.